Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Sales | 1 | 0 | 0 | 42 | 97 |
| Total expenses | 352 | 461 | 156 | 740 | 555 |
| Operating Income | -351 | -461 | -156 | -698 | -458 |
| Interest Expense | 104 | 636 | 137 | 388 | 788 |
| Other Income | -362 | -583 | -3,207 | 0 | 0 |
| Pre-tax Income | -817 | -1,680 | -3,499 | -1,086 | -1,245 |
| Net Income Continuous | -817 | -1,680 | -3,499 | -1,086 | -1,245 |
| Net Income Discontinuous | N/A | N/A | -3 | N/A | N/A |
| Net Income | $-817 | $-1,680 | $-3,502 | $-1,086 | $-1,245 |
| EPS Basic Continuous Ops | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 |
| EPS Basic Total Ops | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 |
| EPS Diluted Continuous Ops | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 |
| EPS Diluted Total Ops | -0.01 | -0.04 | -0.13 | -0.66 | -7.50 |
| EBITDA(a) | $-267 | $48 | $-60 | $-361 | $264 |